CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

Right arrow Help viewing high resolution images
Right arrow Return to article


Fig. 3. PP1 blocks both SCF-mediated Kit and MAPK activation. In A, H526 cells incubated in serum-free medium overnight were either left unstimulated or stimulated for 5 min with 100 ng/ml of SCF after a 30-min pretreatment with the indicated concentrations of PP1. Kit was immunoprecipitated and the immunoprecipitate was immunoblotted with antiphosphotyrosine and anti-Kit antibodies in succession. The degree of Kit activation was calculated by densitometry (ratio of pTyr:Kit signal) and normalized to the SCF-stimulated vehicle control lane which was arbitrarily assigned a value of 100%. Experiment shown is representative of three replicates. In B, cells were treated as above, but after SCF treatment, whole-cell lysates were made in SDS buffer. The lysates were immunoblotted and stained successively with antiphospho-ERK and antipan-ERK antibodies. The degree of activation was calculated as above. Experiment shown is representative of three replicates.





Right arrow Return to article


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation